Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: ETON) | Delayed: 49.30 -0.89 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.19 | 52 Week High | $ | |||
| Open | $50.93 | 52 Week Low | $ | |||
| Day High | $50.93 | P/E | N/A | |||
| Day Low | $48.66 | EPS | $ | |||
| Volume | 318,993 | |||||
